“Luke Evnin”

a.k.a.:  “Evnin, Luke”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  3/7/24  as  ↓Signatory

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Luke Evnin” has been a Group Member with  13  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
2/12/24		MA	MPM BioVentures 2014, L.P.	16	SC 13D/A	CA	Harpoon Therapeutics, Inc.
2/12/24		MA	MPM Bioventures 2018, L.P.	3	SC 13G/A	MA	Dyne Therapeutics, Inc.
2/11/22		MA	Turmeric Management, LLC	1	SC 13G		Turmeric Acquisition Corp.
2/12/21		MA	MPM BioVentures IV QP LP	25	SC 13G/A	MA	Chiasma, Inc.
6/26/20		MA	MPM Bioventures V, L.P.	10	SC 13D/A	MA	Rhythm Pharmaceuticals, Inc.
8/30/18		MA	MPM Bioventures III-QP L.P.	19	SC 13D/A	MA	Radius Health, Inc.
2/13/17		MA	MPM Bioventures III L.P.	28	SC 13G	MD	Vaccinogen Inc.
2/5/15			MPM Bio IV NVS Strategic Fund LP	1	SC 13G	NY	Protara Therapeutics, Inc.
2/5/15		MA	MPM Bioventures II QP LP	10	SC 13G/A	MD	Macrogenics Inc.
2/10/11			BB Bioventures LP	12	SC 13G/A	MA	Idenix Pharmaceuticals Inc.
2/10/11		MA	MPM Bioventures II LP	11	SC 13G/A	CA	Affymax Inc.
2/17/04		MA	MPM Capital LP	1	SC 13G	MA	Oscient Pharmaceuticals Corp.
3/20/03		CA	MPM Bioequities Adviser LLC	2	SC 13D/A	CA	Aradigm Corp.

“Luke Evnin” has/had a Group Member interest in  53  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
2/12/24		CA	Harpoon Therapeutics, Inc.	4	SC 13D/A	MA	MPM BioVentures 2014, L.P.
2/12/24		MA	Dyne Therapeutics, Inc.	3	SC 13G/A	MA	MPM Bioventures 2018, L.P.
2/11/22			Turmeric Acquisition Corp.	1	SC 13G	MA	Turmeric Management, LLC
12/9/21		MA	iTeos Therapeutics, Inc.	4	SC 13D/A	MA	MPM BioVentures 2014, L.P.
11/12/21		MA	Entrada Therapeutics, Inc.	1	SC 13D	MA	MPM BioVentures 2014, L.P.
7/20/21			Repare Therapeutics Inc.	4	SC 13D/A	MA	MPM BioVentures 2014, L.P.
5/14/21		MA	Werewolf Therapeutics, Inc.	1	SC 13D	MA	MPM BioVentures 2014, L.P.
2/12/21		MA	Chiasma, Inc.	5	SC 13G/A	MA	MPM BioVentures IV QP LP
2/12/21		MA	Syndax Pharmaceuticals Inc.	4	SC 13G/A	MA	MPM BioVentures IV QP LP
10/21/20		MA	Oncorus, Inc.	1	SC 13D	MA	MPM BioVentures 2014, L.P.
6/26/20		MA	Rhythm Pharmaceuticals, Inc.	4	SC 13D/A	MA	MPM Bioventures V, L.P.
2/5/20		CA	Histogen Inc.	5	SC 13G/A	MA	MPM BioVentures IV QP LP
3/4/19		MA	TCR2 Therapeutics Inc.	1	SC 13D	MA	MPM BioVentures 2014, L.P.
8/30/18		MA	Radius Health, Inc.	5	SC 13D/A	MA	MPM Bioventures III-QP L.P.
2/13/17		MD	Vaccinogen Inc.	1	SC 13G	MA	MPM Bioventures III L.P.
3/29/16		MD	Altimmune, Inc.	5	SC 13D/A	MA	MPM Bioventures III L.P.
2/9/16		MA	Epizyme, Inc.	3	SC 13G/A	MA	MPM BioVentures IV QP LP
7/21/15		KS	Aratana Therapeutics, Inc.	4	SC 13D/A	MA	MPM Bioventures V, L.P.
2/5/15		CA	Portola Pharmaceuticals Inc.	2	SC 13G/A	MA	MPM Bioventures III-QP L.P.
2/5/15		NJ	Humanigen, Inc.	2	SC 13G/A	MA	MPM Bioventures III L.P.
			More...  Please Sign In to list all 53 of them.

“Luke Evnin” has been a Group Member with  105  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
2/12/24		MA	Gadicke, Ansbert	138	SC 13D/A	MA	MPM BioVentures 2014, L.P.	CA	Harpoon Therapeutics, Inc.
		MA	MPM Asset Management Investors BV2014 LLC	16
		MA	MPM Asset Management LLC	18
		MA	MPM Bioimpact LLC	1
		MA	MPM Bioventures 2014 (B), L.P.	16
		MA	MPM BioVentures 2014 GP LLC	16
		MA	MPM BioVentures 2014 LLC	18
			Oncology Impact Fund (Cayman) Management, L.P.	7
		MA	Todd Foley	56
			UBS Oncology Impact Fund, L.P.	15
2/12/24		MA	MPM Asset Management Investors BV2018 LLC	8	SC 13G/A	MA	MPM Bioventures 2018, L.P.	MA	Dyne Therapeutics, Inc.
		MA	MPM Bioventures 2018 (B), L.P.	8
		MA	MPM Bioventures 2018 GP LLC	8
		MA	MPM Bioventures 2018 LLC	8
2/9/23		•	Ed Hurwitz	2	SC 13G/A	MA	MPM Bioventures 2018, L.P.	MA	Dyne Therapeutics, Inc.
12/9/21		MA	Bioimpact Capital LLC	3	SC 13D/A	MA	MPM BioVentures 2014, L.P.	MA	iTeos Therapeutics, Inc.
		CA	Edward Hurwitz	5
		MA	MPM Bioventures 2018, L.P.	5
9/21/21			Oncology Impact Fund (Cayman) LP	8	SC 13D/A	MA	MPM BioVentures 2014, L.P.	MA	iTeos Therapeutics, Inc.
7/20/21		MA	MPM Oncology Impact Management GP LLC	11	SC 13D/A	MA	MPM BioVentures 2014, L.P.		Repare Therapeutics Inc.
			More...  Please Sign In to list all 105 of them.

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Luke Evnin” has been a Signatory for/with  9  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
3/7/24		MA	Werewolf Therapeutics, Inc.	7	S-8	—
2/12/24		MA	MPM BioVentures 2014, L.P.	13	SC 13D/A	CA	Harpoon Therapeutics, Inc.
2/12/24		MA	MPM Bioventures 2018, L.P.	3	SC 13G/A	MA	Dyne Therapeutics, Inc.
3/24/23		MA	Oncorus, Inc.	11	S-8	—
10/31/22			Turmeric Acquisition Corp.	31	15-12G	—
6/3/22		MA	Evnin Luke	8	4	MA	Werewolf Therapeutics, Inc.
4/15/22			Biotech Acquisition Co.	1	S-4/A	—
2/11/22		MA	Turmeric Management, LLC	2	SC 13G		Turmeric Acquisition Corp.
2/12/21		MA	MPM BioVentures IV QP LP	2	SC 13G/A	MA	Chiasma, Inc.

“Luke Evnin” has/had a Signatory interest in  11  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
2/12/24		CA	Harpoon Therapeutics, Inc.	4	SC 13D/A	MA	MPM BioVentures 2014, L.P.
2/12/24		MA	Dyne Therapeutics, Inc.	3	SC 13G/A	MA	MPM Bioventures 2018, L.P.
6/3/22		MA	Werewolf Therapeutics, Inc.	3	4	MA	Evnin Luke
2/11/22			Turmeric Acquisition Corp.	4	SC 13G	MA	Turmeric Management, LLC
12/9/21		MA	iTeos Therapeutics, Inc.	4	SC 13D/A	MA	MPM BioVentures 2014, L.P.
11/12/21		MA	Entrada Therapeutics, Inc.	1	SC 13D	MA	MPM BioVentures 2014, L.P.
7/20/21			Repare Therapeutics Inc.	3	SC 13D/A	MA	MPM BioVentures 2014, L.P.
2/12/21		MA	Chiasma, Inc.	1	SC 13G/A	MA	MPM BioVentures IV QP LP
2/12/21		MA	Syndax Pharmaceuticals Inc.	2	SC 13G/A	MA	MPM BioVentures IV QP LP
10/21/20		MA	Oncorus, Inc.	2	SC 13D	MA	MPM BioVentures 2014, L.P.
5/18/06		MN	Restore Medical, Inc.	1	4	MA	Evnin Luke